IVF•INVO Fertility will implement a 1-for-4 reverse stock split effective October 30, 2026. The split will reduce outstanding common shares to approximately 1,192,841 and authorized common shares to 62,500,000.
INVO Fertility will implement a 1-for-4 reverse stock split effective at 12:01 a.m. Eastern Time on October 30, 2026. Shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market that day under the unchanged ticker IVF.
After the split, outstanding common shares will total approximately 1,192,841, while authorized common shares will decrease proportionately to 62,500,000.
